Molecular assembly of the KCNQ1-KCNE1-BACE1 complex

This study elucidates the molecular architecture of the KCNQ1-KCNE1-BACE1 complex, demonstrating that BACE1 directly binds to KCNQ1 via its extracellular domain to modulate channel gating and co-assembles with KCNE1 in a 2:1 stoichiometry without disrupting KCNE1's functional effects.

The Gist

Imagine your body is a bustling city, and inside your heart, there are tiny, sophisticated traffic lights that control the flow of electricity. These traffic lights are called KCNQ1 channels. When they work perfectly, your heart beats in a steady, healthy rhythm.

For a long time, scientists knew that these traffic lights needed a specific "assistant" named KCNE1 to work correctly. Think of KCNE1 as a traffic controller who stands next to the light, telling it exactly when to turn green and how fast the cars (electricity) should flow. Without this controller, the light is too fast and erratic.

But recently, scientists discovered a third character in this story: a protein called BACE1. You might know BACE1 from its role in Alzheimer's disease, where it acts like a pair of molecular scissors that cuts other proteins. However, this paper reveals that BACE1 has a secret second job: it acts as a mechanic for the heart's traffic lights, but it doesn't use its scissors. It just uses its physical presence.

Here is the simple story of what this paper discovered, using some fun analogies:

1. The "Lego" Discovery (How they fit together)

The scientists wanted to know: Does BACE1 just hang out near the traffic light, or does it actually click onto it? And does it fight with the traffic controller (KCNE1) for space?

To find out, they used a clever trick called BiFC (Bimolecular Fluorescence Complementation). Imagine taking a glowing yellow lightbulb and cutting it in half. Neither half glows on its own. But if you attach one half to Protein A and the other half to Protein B, and those two proteins hug each other, the lightbulb snaps back together and glows bright yellow.

• The Result: When they attached the halves to KCNQ1 and BACE1, the lightbulb glowed! This proved that BACE1 physically hugs the traffic light. It also glowed when they tested KCNQ1 and KCNE1.
• The Surprise: When they put KCNQ1, KCNE1, and BACE1 all together, the light still glowed. This means BACE1 and KCNE1 can stand next to each other without fighting. They don't kick each other off the bus; they both get a seat.

2. The "Frankenstein" Experiment (Who does what?)

To figure out which part of BACE1 and KCNE1 does the work, the scientists built "Frankenstein" proteins. They took the top half (the outside) of BACE1 and glued it to the bottom half (the inside) of KCNE1, and vice versa.

• The Traffic Controller's Job (KCNE1): They found that the transmembrane part (the part that goes through the wall of the cell) is the most important. If you swap this part, the traffic light changes its speed and timing completely. It's like changing the gears on a car; the whole driving experience changes.
• The Mechanic's Job (BACE1): Surprisingly, BACE1 does its work mostly with its large head (the part sticking out on the outside of the cell). It doesn't need to go deep inside the cell to do its job. It's like a mechanic who fixes the engine by just leaning on the hood and talking to the driver, without ever opening the hood.

The "Super-Combo": When they built a protein with BACE1's big head and KCNE1's body, the traffic light got the best of both worlds: it slowed down (like BACE1 wanted) and changed its timing (like KCNE1 wanted). They are additive, not competitive.

3. The "Crowded Dance Floor" (How many fit?)

A big question in science has been: How many assistants can fit on one traffic light?

The scientists used a technique called SiMPull (Single-Molecule Pull-Down). Imagine trying to count how many people are holding hands in a dark room by watching how many times a flashlight flickers out as they let go one by one.

• The Finding: They discovered that two BACE1 molecules usually attach to one KCNQ1 traffic light.
• The Twist: Before BACE1 attaches to the traffic light, it likes to hang out in groups of two or three (like a small gang). But the moment it sees the KCNQ1 traffic light, it breaks up its gang and attaches individually. The traffic light actually disrupts the BACE1 gang, forcing them to work as individuals to help the channel.

The Big Picture

This paper tells us that the heart's electrical system is more complex and cooperative than we thought.

1. BACE1 is a direct helper: It doesn't just cut things; it physically grabs onto the heart's potassium channels to slow them down and make them work better.
2. No fighting for space: BACE1 and the classic assistant (KCNE1) work together in harmony. They occupy different spots on the channel.
3. Two heads are better than one: The channel usually grabs two BACE1 helpers at a time.

Why does this matter?
Think of the heart as a high-performance engine. If the traffic lights (channels) are too fast, the engine sputters (causing heart rhythm problems). This research shows that BACE1 is a crucial part of the tuning mechanism. Understanding exactly how these three proteins (KCNQ1, KCNE1, and BACE1) hold hands helps scientists design better drugs to fix heart rhythm disorders, and perhaps even understand how BACE1's other role in Alzheimer's might be connected to heart health.

In short: BACE1 isn't just a cutter; it's a partner in the dance of the heart, and it knows exactly how to step in time with the other dancers.

Technical Summary

1. Problem Statement

The KCNQ1 potassium channel is a critical regulator of cellular excitability, particularly in the heart where it forms the $I_{Ks}$ current upon co-assembly with the auxiliary subunit KCNE1. While the structural and functional interplay between KCNQ1 and KCNE1 is well-characterized, the role of the $\beta$-secretase BACE1 (best known for its proteolytic role in Alzheimer's disease) in modulating KCNQ1 remains poorly understood.

Previous work established that BACE1 non-proteolytically modulates KCNQ1 gating. However, key questions remained unresolved:

• How do BACE1 and KCNE1 physically interact with the KCNQ1 tetramer?
• Do they compete for binding sites, or can they co-assemble?
• What are the specific molecular domains responsible for these interactions and functional modulation?
• What is the precise stoichiometry of BACE1 within the channel complex?

2. Methodology

The authors employed a multi-faceted approach combining molecular biology, biophysics, and electrophysiology to dissect the KCNQ1–KCNE1–BACE1 complex:

• Bimolecular Fluorescence Complementation (BiFC): Used to visualize direct physical interactions at the plasma membrane. Split Venus fragments (VN and VC) were fused to the C-termini of KCNQ1, KCNE1, and BACE1.
• Chimeric Constructs: Six chimeric proteins were engineered by swapping the extracellular, transmembrane (TM), and intracellular domains between KCNE1 and BACE1. This allowed for the mapping of specific interaction and functional domains.
• Electrophysiology (Whole-cell Patch-Clamp): Used to characterize the functional consequences of co-expression. Currents were recorded to analyze amplitude, voltage dependence of activation, and activation/inactivation kinetics.
• Single-Molecule Pull-Down (SiMPull): Utilized to determine the stoichiometry of the complexes. HA-tagged bait proteins were immobilized, and fluorescently labeled prey proteins were counted via photobleaching steps.
• Förster Resonance Energy Transfer (FRET): Used to assess BACE1 oligomerization (homomeric assembly) in the presence and absence of KCNQ1 and KCNE1.

3. Key Contributions and Results

A. Validation of Physical Interactions

• KCNQ1 Homotetramerization: BiFC confirmed the known homotetrameric assembly of KCNQ1.
• Specific Binding: BiFC signals confirmed direct physical interactions between KCNQ1 and both KCNE1 and BACE1 at the plasma membrane.
• Chimera Mapping (Interaction):
  • The extracellular domain of BACE1 was found to be critical for physical interaction with KCNQ1. Chimeras containing the BACE1 extracellular domain generally showed strong BiFC signals.
  • Conversely, chimeras combining the BACE1 extracellular domain with the KCNE1 transmembrane domain failed to interact, suggesting steric or structural incompatibility in that specific orientation.

B. Functional Modulation and Domain Specificity

Electrophysiological recordings revealed distinct and additive effects:

• KCNE1 Role: The transmembrane segment of KCNE1 is necessary and sufficient to confer the characteristic $I_{Ks}$ phenotype (slow activation, depolarized voltage shift). The intracellular domain fine-tunes the voltage dependence of activation.
• BACE1 Role: BACE1 primarily slows the activation kinetics of KCNQ1 without significantly altering the voltage dependence. This effect is mediated by the large extracellular domain of BACE1.
• Additivity: The "super-mutant" chimera (BEE), which combines the BACE1 extracellular domain with the KCNE1 transmembrane and intracellular domains, produced a current with both the $I_{Ks}$ phenotype (from KCNE1 domains) and the slowed activation kinetics (from the BACE1 extracellular domain). This confirms that BACE1 and KCNE1 modulate the channel via distinct, non-overlapping mechanisms.

C. Stoichiometry and Oligomerization

• BACE1 Stoichiometry: SiMPull and photobleaching-step analysis demonstrated that a single KCNQ1 tetramer predominantly recruits two BACE1 molecules.
• Disruption of BACE1 Oligomers: While BACE1 naturally forms dimers and trimers at the plasma membrane, co-expression with KCNQ1 significantly reduced BACE1 homomeric assembly (as shown by BiFC intensity reduction and FRET efficiency).
• Independence from KCNE1: The disruption of BACE1 homomers by KCNQ1 occurred regardless of whether KCNE1 was present, indicating that KCNQ1 binding does not require KCNE1 and that BACE1 and KCNE1 occupy distinct sites on the channel.

4. Significance

This study provides a comprehensive molecular model for the regulation of KCNQ1 channels:

1. Non-Proteolytic Mechanism: It reinforces that BACE1 acts as a direct modulator of ion channel gating independent of its enzymatic cleavage activity.
2. Structural Model: It proposes a model where a KCNQ1 tetramer binds two BACE1 molecules and up to four KCNE1 molecules simultaneously. BACE1 binds via its extracellular domain, while KCNE1 binds via its transmembrane and intracellular domains, allowing for co-assembly without competition.
3. Physiological Implications: The findings suggest a complex regulatory layer for cardiac and epithelial potassium channels. The ability of BACE1 to modulate $I_{Ks}$ kinetics independently of KCNE1 could have implications for cardiac repolarization and potentially link metabolic states (via ATP sensitivity mentioned in previous work) to channel function.
4. Therapeutic Potential: Understanding the specific domains involved (e.g., BACE1's extracellular region) opens new avenues for developing non-proteolytic modulators of KCNQ1 channels, which could be relevant for treating Long QT syndrome or other channelopathies without interfering with BACE1's role in amyloid processing.

In conclusion, the paper establishes that BACE1 is a direct, non-enzymatic regulator of KCNQ1 that co-assembles with the channel and its canonical subunit KCNE1, utilizing specific extracellular and transmembrane interfaces to fine-tune channel gating.